Trial Outcomes & Findings for Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation (NCT NCT02005445)

NCT ID: NCT02005445

Last Updated: 2019-07-05

Results Overview

Functional status as measured by the World Health Organization Disability Assessment Scale 2.0. Score range 0-48 (higher scores indicate more disability).

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

4 participants

Primary outcome timeframe

12 weeks

Results posted on

2019-07-05

Participant Flow

Participant milestones

Participant milestones
Measure
CPAP
Continuous positive airway pressure CPAP: Continuous positive airway pressure
HLSE
Healthy living and sleep education HLSE: Healthy living and sleep education
Overall Study
STARTED
2
2
Overall Study
COMPLETED
2
1
Overall Study
NOT COMPLETED
0
1

Reasons for withdrawal

Reasons for withdrawal
Measure
CPAP
Continuous positive airway pressure CPAP: Continuous positive airway pressure
HLSE
Healthy living and sleep education HLSE: Healthy living and sleep education
Overall Study
Dual study enrollment
0
1

Baseline Characteristics

Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
CPAP
n=2 Participants
Continuous positive airway pressure CPAP: Continuous positive airway pressure
HLSE
n=2 Participants
Healthy living and sleep education HLSE: Healthy living and sleep education
Total
n=4 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Age, Categorical
>=65 years
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Sex: Female, Male
Female
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Male
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
White
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Apnea-hypopnea index
19.7 events/hour
n=5 Participants
25.8 events/hour
n=7 Participants
19.9 events/hour
n=5 Participants

PRIMARY outcome

Timeframe: 12 weeks

Population: As we were unable to recruit a sufficient number of patients for meaningful analysis, due to closing of the cardiac Rehabilitation program, no analysis was performed. Because there were only 1-2 participants completing the study in each arm, data are not presented due too confidentiality concerns.

Functional status as measured by the World Health Organization Disability Assessment Scale 2.0. Score range 0-48 (higher scores indicate more disability).

Outcome measures

Outcome data not reported

Adverse Events

CPAP

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

HLSE

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
CPAP
n=2 participants at risk
Continuous positive airway pressure CPAP: Continuous positive airway pressure
HLSE
n=2 participants at risk
Healthy living and sleep education HLSE: Healthy living and sleep education
Cardiac disorders
Chest Pain
0.00%
0/2 • 3 months
50.0%
1/2 • Number of events 1 • 3 months

Additional Information

Dr. Daniel Gottlieb

VA Boston Healthcare System

Phone: 857-203-6375

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place